LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 51 filers reported holding LOXO ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $33,757,000 | -18.7% | 1,289,420 | -28.1% | 1.52% | -29.7% |
Q2 2016 | $41,543,000 | -15.2% | 1,792,207 | 0.0% | 2.16% | -33.7% |
Q1 2016 | $48,999,000 | -3.9% | 1,792,207 | 0.0% | 3.25% | +0.2% |
Q4 2015 | $50,988,000 | +62.8% | 1,792,207 | 0.0% | 3.25% | +57.3% |
Q3 2015 | $31,328,000 | -3.0% | 1,792,207 | 0.0% | 2.06% | +22.3% |
Q2 2015 | $32,313,000 | +44.8% | 1,792,207 | 0.0% | 1.69% | +67.2% |
Q1 2015 | $22,313,000 | +6.0% | 1,792,207 | 0.0% | 1.01% | -1.2% |
Q4 2014 | $21,058,000 | – | 1,792,207 | – | 1.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 3,452,493 | $45,330,000 | 8.79% |
BVF INC/IL | 1,192,202 | $15,654,000 | 3.25% |
Redmile Group, LLC | 540,300 | $7,094,000 | 0.82% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,591,546 | $20,897,000 | 0.76% |
Orbimed Advisors | 2,175,857 | $28,569,000 | 0.30% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 365,566 | $4,800,000 | 0.18% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 75,000 | $985,000 | 0.13% |
RS INVESTMENT MANAGEMENT CO LLC | 599,400 | $7,870,000 | 0.07% |
Visium Asset Management, LP | 332,516 | $4,366,000 | 0.06% |
Nicholas Investment Partners, LP | 73,341 | $963,000 | 0.06% |